![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
2028년까지 유럽 의료 규제 업무 아웃소싱 시장 예측 – 서비스 유형별 코로나19 영향 및 지역 분석(규제 및 과학 전략 개발, 의료 및 과학 글쓰기, eCTD 및 전자 제출, 데이터 관리 서비스, 수명 주기 관리 서비스, 약물 감시, 화학) 제조 및 제어(CMC) 서비스, 규제 라벨링 및 규제 삽화 서비스) 및 최종 사용자(제약 회사, 생명 공학 회사 및 의료 기기 회사)
시장 소개
유럽 의료 규제 업무 아웃소싱 시장에는 독일, 프랑스, 이탈리아, 스페인, 영국 및 유럽의 나머지 지역. 현지 시장에서 신속한 승인을 목표로 하는 기업의 지리적 확장 활동의 증가는 유럽 지역에서 이 시장의 성장을 이끄는 주요 요인이 될 것으로 예상됩니다. 그러나 가격 변동으로 이어지는 통제력 상실과 기술 발전으로 인해 예측 기간 동안 시장 성장이 저해될 것으로 예상됩니다. 상환 시나리오의 변화와 가격 압박으로 인해 독일 제약 및 의료기기 회사의 비용 절감 조치 채택이 늘어날 것으로 예상됩니다. 이는 규제업무 아웃소싱의 해외화를 촉진할 것으로 예상된다. 제약회사는 고품질 문서 확보, R&D 비용 통제, 규제업무팀 교육에 필요한 투자비용 절감을 위해 규제업무 서비스를 아웃소싱하고 있습니다. 또한, 제약 및 의료기기 회사는 비즈니스 활동을 다양화하고 제품 수명주기를 관리하기 위해 규제 업무 서비스를 아웃소싱하고 있습니다. 신제품의 신속한 승인에 대한 수요 증가는 유럽 의료 규제 업무 아웃소싱 시장의 성장을 이끄는 주요 요인입니다.
유럽에서는 코로나19 사례가 기하급수적으로 증가했습니다. 이 지역의 많은 국가에서는 첫 번째 물결 동안 하루에 많은 수의 환자가 발생했습니다. 유럽질병예방통제센터(ECDC)에 따르면 2차 확산이 시작되면서 2020년 하반기에 영국, 스페인, 이탈리아, 아일랜드에서 사교 모임 금지 조치가 다시 도입되었습니다. 정부는 시험 역량 강화에 우선순위를 두고 있다. 기하급수적으로 증가하는 감염률은 지역의 의료 시스템에 높은 부담을 가하고 있으며, 의료 시스템에서 진단 테스트에 대한 수요를 증가시키고 이 지역의 부문 확장을 지원하고 있습니다. 코로나19 팬데믹으로 인해 연구 개발, 제조, 공급망 및 약물 개발에 중요한 거의 모든 구성 요소가 지연되었습니다. 개발 프로세스에 중요한 검토 팀이나 기관의 피드백을 기다리는 시간이 길어 규제 기관과의 커뮤니케이션이 예측 불가능해졌습니다. 또한 일정의 촉박함과 24시간 직원 가용성은 시장 참여자들이 직면한 특별한 과제입니다. 그러나 코로나19 팬데믹에 대응하여 진행 중인 수많은 임상시험이 임상시험 서비스 부문의 성장에 기여하고 있습니다. 코로나19 질병에 대한 효과적인 치료법과 백신을 식별하고 상용화해야 하는 시급함으로 인해 유럽 전역에서 임상 시험 수가 증가했습니다. 또한 임상시험 승인 시간 단축, 대기 기간 면제, 지침 문서 게시, 임상시험에 대한 규제 자금 지원 등을 위한 지원 규제 조치로 인해 부문 성장이 더욱 촉진될 것으로 예상됩니다.
시장 개요 및 역학
유럽의 의료 규제 업무 아웃소싱 시장은 2021년 19억 4,890만 달러에서 2028년 39억 5,754만 달러로 성장할 것으로 예상됩니다. 2021년부터 2028년까지 연평균 성장률(CAGR) 10.6%로 성장할 것으로 예상됩니다. 전통적인 약물 개발 접근 방식의 지속적인 업그레이드와 발전은 의료 부문에서 심각한 과제를 야기하고 있습니다. 제약회사와 의료 단체에는 처방약 비용을 줄여야 한다는 엄청난 압력이 가해지고 있는 반면 운영 비용은 치솟고 있습니다. 규제 요건의 복잡성, 블록버스터 약품의 특허 만료로 인한 수익 감소, 정부와 의료 보험사의 의료 비용 절감 압력으로 인해 의료 산업에 추가적인 과제가 제기되었습니다. 이러한 어려움을 감안하여 제약회사는 전문적인 외부 소스가 제공하는 전문 지식과 함께 자원을 활용할 필요성을 깨달았습니다. 많은 고급 규제 컨설팅 회사는 전체 제품 수명주기에 걸쳐 전문 지식을 제공하고 있습니다. 규제 업무를 아웃소싱하면 후원자는 경험을 쌓고 비용을 최적화하며 생산성을 향상시킬 수 있습니다. 규제 아웃소싱 회사는 규제 요구 사항을 평가할 수 있는 더 나은 위치에 있으므로 최상의 솔루션을 선택할 수 있습니다. 이들은 규제 출판 시스템의 구현, 운영 및 유지 관리와 관련된 이해에 정통합니다. 대부분의 대형 제약 및 생명공학 회사는 규제 및 약물 감시 서비스 지원도 제공할 수 있는 컨설팅 회사를 찾습니다. 규제 서류 제출의 복잡성이 증가함에 따라 전문 CRO 전문 지식에 대한 수요가 강조되었습니다. 제품 개발 초기 단계에서 의료 규제 준수 조치와 함께 제품별 규제 조언 및 전략을 계획하는 것은 제품의 규제 승인을 위해 매우 중요합니다. 개발 초기 단계에서 규정 준수 문제를 해결하지 못하면 부적절하게 제출된 문서, 제조 감독, 규제 연구 생략 및 기타 규제 요구 사항 충족 실패로 인해 승인 프로세스가 지연되는 경우가 많습니다. 이제 의료 기업은 핵심 역량에 집중하고 비핵심 기능은 아웃소싱하여 생산성과 운영 효율성을 향상시키고 있습니다. 따라서 의료 기업에 대한 규제 압력 증가가 시장 성장을 주도할 것으로 예상됩니다.
주요 시장 부문
유럽 의료 규제 업무 아웃소싱 시장은 서비스 유형, 최종 사용자 및 국가를 기준으로 분류되었습니다. 서비스 유형을 기준으로 유럽 의료 규제 업무 아웃소싱 시장은 의료 및 의료 부문으로 분류됩니다. 과학 저술, 약물 감시, 데이터 관리 서비스, 수명 주기 관리 서비스, eCTD 및 전자 제출, 규제 및 과학 전략 개발, 화학 제조 및 제어(CMC) 서비스, 규제 라벨링 및 규제 삽화 서비스. 의료 & 2020년에는 과학 글쓰기 부문이 시장을 장악했으며 약물 감시 부문은 예측 기간 동안 가장 빠르게 성장할 것으로 예상됩니다. 최종 사용자를 기준으로 시장은 제약 회사, 생명 공학 회사 및 의료 기기 회사로 분류됩니다. 제약 회사 부문은 2020년 시장을 지배했으며 예측 기간 동안 가장 빠르게 성장할 것으로 예상됩니다. 마찬가지로, 분류된 의료기기 회사는 의료기기 소재 및 의료기기 소재로 분류됩니다. 생체재료, 의료기기, 바이오마커 및 체외진단(IVD), 의료기기 소프트웨어(SaMD), 의료기기 전기기계, 의료기기 물질 기반, 복합제품의 의료기기
주요 소스 및 나열된 회사
유럽의 의료 규제 업무 아웃소싱 시장에 대한 이 보고서를 준비하기 위해 참조된 몇 가지 주요 1차 및 2차 소스로는 회사 웹사이트, 연례 보고서, 재무 보고서, 국가 정부 문서, 통계 데이터베이스 등이 있습니다. 보고서에 나열된 주요 회사로는 Arriello Ireland Ltd., Asphalion SL, Azierta Contract Science Support Consulting, DRA CONSULTING OY, IQVIA Inc., KLIFO, PAREXEL INTERNATIONAL CORPORATION, PHARMALEX GMBH, ProductLife Group, ProPharma Group 및 Voisin Consulting Life Sciences( VCLS).
구매 이유 보고서
- 유럽 의료 규제 업무 아웃소싱 시장 환경을 이해하고 강력한 수익을 보장할 가능성이 가장 높은 시장 부문을 식별합니다.
- 유럽 의료 규제 업무 아웃소싱 시장의 끊임없이 변화하는 경쟁 환경
- 가장 유망한 판매 가능성이 있는 시장 부문을 식별하여 유럽 의료 규제 업무 아웃소싱 시장에서 M&A 및 파트너십 거래를 효율적으로 계획합니다.
- 유럽 의료 규제 업무 아웃소싱 시장의 다양한 부문의 시장 성과에 대한 통찰력 있고 포괄적인 분석을 통해 지식이 풍부한 비즈니스 결정을 내리는 데 도움이 됩니다.
- 2021~2028년 유럽 지역의 다양한 부문별 시장 수익 예측을 얻습니다..
유럽 의료 규제 업무 아웃소싱 시장 세분화
유럽 의료 규제 업무 아웃소싱 시장 –별 서비스 유형
- 의료 및amp; 과학 저술
- 약물 감시
- 데이터 관리 서비스
- 수명주기 관리 서비스
- eCTD 및 전자 제출
- 규제 및 과학 전략 개발
- 화학 제조 및 제어(CMC) 서비스
- 규제 라벨링
- 규제 삽화 서비스
유럽 의료 규제 업무 아웃소싱 시장 - 최종 사용자별
- 제약 회사
- 생명공학 회사
- 의료기기 회사
- 의료기기 재료 및amp; 생체재료
- 의료기기 바이오마커 및 체외진단(IVD)
- 의료기기 소프트웨어(SaMD)
- 의료기기 전기기계
- 의료기기 물질 기반
- 복합 제품의 의료 기기
유럽 의료 규제 업무 아웃소싱 시장 -국가별
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 유럽 나머지 지역
유럽 의료 규제 업무 아웃소싱 시장 -회사 프로필
- Arriello Ireland Ltd.
- Asphalion SL
- Azierta 계약 과학 지원 컨설팅
- DRA CONSULTING OY
- IQVIA Inc.
- KLIFO
- PAREXEL INTERNATIONAL CORPORATION
- PHARMALEX GMBH
- ProductLife Group
- ProPharma 그룹
- Voisin Consulting Life Sciences(VCLS)
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Healthcare Regulatory Affairs Outsourcing Market – By Service Type
1.3.2 Europe Healthcare Regulatory Affairs Outsourcing Market – By End User
1.3.3 Europe Healthcare Regulatory Affairs Outsourcing Market – By Country
2. Europe Healthcare Regulatory Affairs Outsourcing Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Healthcare Regulatory Affairs Outsourcing Market – Market Landscape
4.1 Overview
4.2 Expert Opinions
5. Europe Healthcare Regulatory Affairs Outsourcing Market– Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Regulatory Pressure on Healthcare Companies
5.1.2 Rise in Demand for Speedy Approval of New Products
5.2 Market Restraints
5.2.1 Lack of Skilled Professionals
5.3 Market Opportunities
5.3.1 Advancements in Specialty Therapies, Orphan Drugs, and Personalized Medicines
5.4 Future Trends
5.4.1 Surging Market Consolidation Activities
5.5 Impact Analysis
6. Healthcare Regulatory Affairs Outsourcing Market – Europe Analysis
6.1 Europe Healthcare Regulatory Affairs Outsourcing Market Revenue Forecast and Analysis
7. Europe Healthcare Regulatory Affairs Outsourcing Market Analysis – By Service Type
7.1 Overview
7.2 Healthcare Regulatory Affairs Outsourcing Market, by Service Type (2021 and 2028)
7.3 Regulatory and Scientific Strategy Development
7.3.1 Overview
7.3.2 Regulatory and Scientific Strategy Development: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Medical and Scientific Writing
7.4.1 Overview
7.4.2 Medical and Scientific Writing: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.5 eCTD and E-Submissions
7.5.1 Overview
7.5.2 eCTD and E-Submissions: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Data Management Services
7.6.1 Overview
7.6.2 Data Management Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Life Cycle Management Services
7.7.1 Overview
7.7.2 Life Cycle Management Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Pharmacovigilance
7.8.1 Overview
7.8.2 Pharmacovigilance : Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.9 Chemistry Manufacturing and Controls (CMC) Services
7.9.1 Overview
7.9.2 Chemistry Manufacturing & Controls ((CMC) Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.10 Regulatory Labelling
7.10.1 Overview
7.10.2 Regulatory Labelling : Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.11 Regulatory Artwork Services
7.11.1 Overview
7.11.2 Regulatory Artwork Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
8. Europe Healthcare Regulatory Affairs Outsourcing Market Analysis – By End User
8.1 Overview
8.2 Healthcare Regulatory Affairs Outsourcing Market, by End-User (2020 and 2028)
8.3 Pharmaceutical Companies
8.3.1 Overview
8.3.2 Pharmaceutical Companies: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Biotechnology Companies
8.4.1 Overview
8.4.2 Biotechnology Companies : Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Medical Device Companies
8.5.1 Overview
8.5.2 Medical Device Companies: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
8.5.2.1 Medical Device Software (SaMD) Market
8.5.2.1.1 Overview
8.5.2.1.2 Medical Device Software (SaMD) Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
8.5.2.2 Medical Device Materials & Biomaterials Market
8.5.2.2.1 Overview
8.5.2.2.2 Medical Device Materials & Biomaterials Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
8.5.2.3 Medical Device Biomarkers and In-vitro Diagnostics (IVD) Market
8.5.2.3.1 Overview
8.5.2.3.2 Medical Device Biomarkers and In-vitro Diagnostics (IVD) Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
8.5.2.4 Medical Device Electro mechanics Market
8.5.2.4.1 Overview
8.5.2.4.2 Medical Device Electro mechanics Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
8.5.2.5 Medical Device Substance Based Market
8.5.2.5.1 Overview
8.5.2.5.2 Medical Device Substance Based Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
8.5.2.6 Medical Device of Combination Product (DDC) Market
8.5.2.6.1 Overview
8.5.2.6.2 Medical Device of Combination Product (DDC) Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
9. Europe Healthcare Regulatory Affairs Outsourcing Market – Country Analysis
9.1.1 Europe Healthcare Regulatory Affairs Outsourcing Market Revenue and Forecasts to 2028, By Country (%)
9.1.1.1 Germany Healthcare Regulatory Affairs Outsourcing Market Revenue and Forecasts to 2028 (US$ Mn)
9.1.1.1.1 Germany Healthcare Regulatory Affairs Outsourcing Market Revenue and Forecasts to 2028 (US$ Mn)
9.1.1.1.2 Germany Healthcare Regulatory Affairs Outsourcing Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
9.1.1.1.3 Germany Healthcare Regulatory Affairs Outsourcing Market Revenue and Forecasts to 2028, by End User (US$ Mn)
9.1.1.1.3.1 Germany Healthcare Regulatory Affairs Outsourcing Market Revenue and Forecasts to 2028, by Medical Device Companies (US$ Mn)
9.1.1.2 France Healthcare Regulatory Affairs Outsourcing Market Revenue and Forecasts to 2028 (US$ Mn)
9.1.1.2.1 France: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.2 France Healthcare Regulatory Affairs Outsourcing : Market, By Service Type, 2019–2028 (USD Million)
9.1.1.2.3 France: Healthcare Regulatory Affairs Outsourcing Market, by End User, 2019–2028 (USD Million)
9.1.1.2.3.1 France: Healthcare Regulatory Affairs Outsourcing Market, by Medical Device Companies, 2019–2028 (USD Million)
9.1.1.3 UK: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.1 UK: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.2 UK: Contract Research Organization (CRO) Market, By Service Type, 2019–2028 (USD Million)
9.1.1.3.3 UK: Contract Research Organization (CRO) Market, by End User, 2019–2028 (USD Million)
9.1.1.3.3.1 UK: Contract Research Organization (CRO) Market, by Medical Device Companies, 2019–2028 (USD Million)
9.1.1.4 Italy: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.1 Italy: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.2 Italy: Healthcare Regulatory affairs outsourcing Market, By Service Type, 2019–2028 (USD Million)
9.1.1.4.3 Italy Healthcare Regulatory affairs outsourcing Market, by End User, 2019–2028 (USD Million)
9.1.1.4.3.1 Italy: Healthcare Regulatory affairs outsourcing Market, by Medical Device Companies, 2019–2028 (USD Million)
9.1.1.5 Spain: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.1 Spain: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.2 Spain: Healthcare Regulatory Affairs Outsourcing Market, By Service Type, 2019–2028 (USD Million)
9.1.1.5.3 Spain: Healthcare Regulatory Affairs Outsourcing Market, by End User, 2019–2028 (USD Million)
9.1.1.5.3.1 Spain: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies, 2019–2028 (USD Million)
9.1.1.6 Rest of Europe: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.1 Rest of Europe: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.2 Rest of Europe: Healthcare Regulatory Affairs Outsourcing Market, By Service Type, 2019–2028 (USD Million)
9.1.1.6.3 Rest of Europe: Healthcare Regulatory Affairs Outsourcing Market, by End User, 2019–2028 (USD Million)
9.1.1.6.3.1 Rest of Europe: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies, 2019–2028 (USD Million)
10. Impact Of COVID-19 Pandemic on Europe Healthcare Regulatory Affairs Outsourcing Market
10.1 Overview
11. Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 KLIFO
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 ProPharma Group
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Arriello Ireland Ltd.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 DRA CONSULTING OY
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Asphalion S.L
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 PAREXEL INTERNATIONAL CORPORATION
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 IQVIA Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 PHARMALEX GMBH
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 ProductLife Group
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Voisin Consulting Life Sciences (VCLS)
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Azierta Contract Science Support Consulting
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe Healthcare Regulatory Affairs Outsourcing Market Revenue and Forecast to 2028 (US$ Million)
Table 2. Germany Healthcare Regulatory Affairs Outsourcing Market Revenue and Forecasts to 2028, By Service Type US$ Mn)
Table 3. Germany Healthcare Regulatory Affairs Outsourcing Market Revenue and Forecasts to 2028, by End User US$ Mn)
Table 4. Germany Healthcare Regulatory Affairs Outsourcing Market Revenue and Forecasts to 2028, by Medical Device Companies US$ Mn)
Table 5. France: Healthcare Regulatory Affairs Outsourcing Market, By Service Type – Revenue and Forecast to 2028 (USD Million)
Table 6. France: Healthcare Regulatory Affairs Outsourcing Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 7. France Healthcare Regulatory Affairs Outsourcing Market, by Medical Device Companies– Revenue and Forecast to 2028 (USD Million)
Table 8. UK: Contract Research Organization (CRO) Market, By Service Type – Revenue and Forecast to 2028 (USD Million)
Table 9. UK: Contract Research Organization (CRO) Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 10. UK Contract Research Organization (CRO) Market, by Medical Device Companies– Revenue and Forecast to 2028 (USD Million)
Table 11. Italy: Healthcare Regulatory affairs outsourcing Market, By Service Type – Revenue and Forecast to 2028 (USD Million)
Table 12. Italy: Healthcare Regulatory affairs outsourcing Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 13. Italy Healthcare Regulatory affairs outsourcing Market, by Medical Device Companies– Revenue and Forecast to 2028 (USD Million)
Table 14. Spain: Healthcare Regulatory Affairs Outsourcing Market, By Service Type – Revenue and Forecast to 2028 (USD Million)
Table 15. Spain: Healthcare Regulatory Affairs Outsourcing Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 16. Spain Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies– Revenue and Forecast to 2028 (USD Million)
Table 17. Rest of Europe: Healthcare Regulatory Affairs Outsourcing Market, By Service Type – Revenue and Forecast to 2028 (USD Million)
Table 18. Rest of Europe: Healthcare Regulatory Affairs Outsourcing Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 19. Rest of Europe Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies – Revenue and Forecast to 2028 (USD Million)
Table 20. Organic Developments in the Healthcare Regulatory Affairs Outsourcing Market
Table 21. Inorganic Developments in the Healthcare Regulatory Affairs Outsourcing Market
Table 22. Glossary of Terms, Healthcare Regulatory Affairs Outsourcing Market
LIST OF FIGURES
Figure 1. Europe Healthcare Regulatory Affairs Outsourcing Market Segmentation
Figure 2. Europe Healthcare Regulatory Affairs Outsourcing Market Segmentation, By Country
Figure 3. Europe Healthcare Regulatory Affairs Outsourcing Market Overview
Figure 4. Medical & Scientific Writing Segment Held the Largest Share of the Service Type Segment in Europe Healthcare Regulatory Affairs Outsourcing Market
Figure 5. Germany to Show Significant Growth During Forecast Period
Figure 6. Europe PEST Analysis
Figure 7. Europe Healthcare Regulatory Affairs Outsourcing Market Impact Analysis of Driver and Restraints
Figure 8. Europe Healthcare Regulatory Affairs Outsourcing Market – Revenue Forecast and Analysis – 2019- 2028
Figure 9. Europe Healthcare Regulatory Affairs Outsourcing Market Revenue Share, by Service Type (2020 and 2028)
Figure 10. Europe Regulatory and Scientific Strategy Development: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Europe Medical and Scientific Writing: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Europe eCTD and E-Submissions: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Europe Data Management Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Europe Life Cycle Management Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Europe Pharmacovigilance : Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Europe Chemistry Manufacturing & Controls ((CMC) Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Europe Regulatory Labelling: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Europe Regulatory Artwork Services : Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Europe Healthcare Regulatory Affairs Outsourcing Market Revenue Share, by End-User (2020 and 2028)
Figure 20. Europe Pharmaceutical Companies : Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Europe Biotechnology Companies: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Europe Medical Device Companies: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Europe Medical Device Software (SaMD) Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Europe Medical Device Materials & Biomaterials Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Europe Medical Device Biomarkers and In-vitro Diagnostics (IVD) Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Europe Medical Device Electro mechanics Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Europe Medical Device Substance Based Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Europe Medical Device of Combination Product (DDC) Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Europe: Healthcare Regulatory Affairs Outsourcing Market Revenue Overview, by Country, 2021 (US$ MN)
Figure 30. Europe Healthcare Regulatory Affairs Outsourcing Market Revenue and Forecasts to 2028, By Country (%)
Figure 31. Germany Healthcare Regulatory Affairs Outsourcing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 32. France: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
Figure 33. UK: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
Figure 34. Italy: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. Spain: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
Figure 36. Rest of Europe: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
Figure 37. Impact of COVID-19 Pandemic in European Country Markets
- Arriello Ireland Ltd.
- Asphalion S.L
- Azierta Contract Science Support Consulting
- DRA CONSULTING OY
- IQVIA Inc.
- KLIFO
- PAREXEL INTERNATIONAL CORPORATION
- PHARMALEX GMBH
- ProductLife Group
- ProPharma Group
- Voisin Consulting Life Sciences (VCLS)
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe Healthcare Regulatory Affairs Outsourcing market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Europe Healthcare Regulatory Affairs Outsourcing market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Healthcare Regulatory Affairs Outsourcing market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution